NCT00993408View on ClinicalTrials.gov

Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Pulmonary Arterial Hypertension
Interventions
DEVICE

ACT-293987 (NS-304)

Trial Locations (8)

1090

Medizinische Universitat Wien, Universitatsklinik fur Innere Medizin II, Kardiologie, Vienna

3000

Gasthuisberg University Hospital, Pneumology, Leuven

30625

Department of Respiratory Medicine, Hannover Medical School, Hanover

40138

Hospital Sant'Orsola Malpighi, Cardiology's Department, Bologna

Unknown

Hopital Antoine Beclere, Pneumologie, Paris

H-1125

Semmelweis University, Clinic of Pulmonology, Budapest

01-138

Instytut Gruzilcy i Chorob Pluc, Klinika Chorob Wewnetrznych Klatki Piersiowej, Warsaw

W12 0HS

Hammersmith Hospital, London

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT00993408 - Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH) | Biotech Hunter | Biotech Hunter